Skip to main content
Adam Hartman, MD, Child Neurology, Baltimore, MD

AdamLindsayHartmanMD

Child Neurology Baltimore, MD

Epilepsy

Program Director, Division of Clinical Research, National Institute of Neurological Disorders and Stroke, Adjunct Associate Professor of Neurology and Pediatrics, Johns Hopkins School of Medicine

Dr. Hartman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hartman's full profile

Already have an account?

  • Office

    1800 Orleans St.
    Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone+1 410-955-9100
    Fax+1 410-614-0373

Summary

  • Dr. Adam Hartman is a Program Director in the Division of Clinical Research at NINDS with a background in child neurology and epilepsy. Before joining NINDS, he was an Associate Professor of Neurology and Pediatrics at Johns Hopkins School of Medicine, with a joint appointment in the Johns Hopkins Bloomberg School of Public Health Department of Molecular Microbiology and Immunology. He also was Co-Director of the Neurosciences Intensive Care Nursery and Associate Program Director for the Child Neurology residency at Johns Hopkins. Dr. Hartman earned a bachelor's degree in Chemistry from Northwestern University and an MD from Northwestern University Medical School. During medical school, he was an HHMI-NIH Research Scholar at NIMH. After completing a residency in Pediatrics in the National Capital Uniformed Services Pediatric Residency Program, he served as a general pediatrician in the US Navy for five years (the last as Division Head of General Pediatrics at Naval Medical Center San Diego). He completed his residency in child neurology and a fellowship in clinical neurophysiology/pediatric epilepsy, both at Johns Hopkins. During his training, he studied the mechanism of the ketogenic diet at NINDS. As a faculty member at Johns Hopkins, his lab and clinical research on novel metabolism-based treatments for epilepsy was funded by NIH, the State of Maryland, and private sources. He also has published clinical research in child neurology, with an emphasis on the treatment of medically intractable epilepsy in childhood. His current interests include clinical trials in child neurology, epilepsy, and rare diseases. He is clinically active as a consultant in the Undiagnosed Diseases Program and other select protocols at the NIH Clinical Center.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2005 - 2007
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Child Neurology, 2002 - 2005
  • National Capital Consortium
    National Capital ConsortiumResidency, Pediatrics, 1995 - 1997
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1994

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1996 - 2026
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Epilepsy

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014-2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • KCTD7 Deficiency Defines a Distinct Neurodegenerative Disorder with a Conserved Autophagy‐Lysosome Defect  
    Marsha Pratt, Katrina Peariso, Adam L Hartman, Adolfo Garnica, Satish Agadi, Gerard T Berry, Tobias Loddenkemper, Thomas A Burrow, Pankaj B Agrawal, Annals of Neurology

Press Mentions

  • Reassuring Findings for Antiseizure Medications in Pregnancy
    Reassuring Findings for Antiseizure Medications in PregnancyJune 10th, 2021
  • News from the American Epilepsy Society Annual Meeting: Cannabidiol Research Offers Hope for Seizure Disorders
    News from the American Epilepsy Society Annual Meeting: Cannabidiol Research Offers Hope for Seizure DisordersJanuary 19th, 2017
  • Dom D’Agostino on Disease Prevention, Cancer, and Living Longer
    Dom D’Agostino on Disease Prevention, Cancer, and Living LongerSeptember 25th, 2016
  • Join now to see all